NLSUI OPAC header image

Guide EU pharmaceutical regulatory law

By: Contributor(s): Publication details: The Hague Wolter Kluwer 2011Description: 680p xxixSubject(s): DDC classification:
  • 344.04233 SHO
Contents:
TABLE OF CONTENTS: About the Editor and Authors; Foreword; List of Abbreviations; Brexit; CHAPTER 1 Overview of European Pharmaceutical Regulatory Requirements; Sally Shorthose; CHAPTER 2 Overview of Intellectual Property Rights; Sally Shorthose & Tasmina Goraya; CHAPTER 3 Clinical Trials; Sally Shorthose; CHAPTER 4 Obtaining a Marketing Authorisation Sally Shorthose & Sarah Faircliffe; CHAPTER 5 Conditional Marketing Authorisations; Sally Shorthose; CHAPTER 6 Supplementary Protection Certificates; Tasmina Goraya; CHAPTER 7 Paediatrics; Sally Shorthose & Sarah Faircliffe; CHAPTER 8 Advertising Medicinal Products for Human Use; Anne-Charlotte Le Bihan, Jean-Baptiste Thiénot, Sally Shorthose, Sarah Faircliffe, Marc Martens, Nicolas Carbonnelle, Ulf Grundmann, Hanneke Later-Nijland, Mauro Turrini, Gabriel Lidman & Raquel Ballesteros; CHAPTER 9 Pharmacovigilance; Sally Shorthose CHAPTER 10 Variations to Marketing Authorisations; Tasmina Goraya; CHAPTER 11 Combination Products; Sarah Faircliffe; CHAPTER 12 Abridged Procedure; Hanneke Later-Nijland; CHAPTER 13 Orphan Drugs; Sarah Faircliffe; CHAPTER 14 Biopharmaceuticals; Marc Martens & Nicolas Carbonnelle; CHAPTER 15 Homeopathic, Herbal, and Traditional Herbal Medicinal Products; Hanneke Later-Nijland; CHAPTER 16 Advanced Therapy Medicinal Products; Marc Martens & Nicolas Carbonnelle; CHAPTER 17 Vaccines; Raquel Ballesteros; CHAPTER 18 Medical Devices; Ulf Grundmann, Alexander Csaki, Clarissa Junge-Gierse & David Janiszewski; CHAPTER 19 Parallel Trade; Hanneke Later-Nijland; CHAPTER 20 Competition Law in the Pharmaceutical Sector José Rivas & Silvia Pronk; Appendix Guidelines and Publications; Table of Cases; Directives; Other Legislation; Regulations; Index.
Star ratings
    Average rating: 0.0 (0 votes)

TABLE OF CONTENTS:
About the Editor and Authors;
Foreword;
List of Abbreviations;
Brexit;
CHAPTER 1 Overview of European Pharmaceutical Regulatory Requirements;
Sally Shorthose;
CHAPTER 2 Overview of Intellectual Property Rights;
Sally Shorthose & Tasmina Goraya;
CHAPTER 3 Clinical Trials;
Sally Shorthose;
CHAPTER 4 Obtaining a Marketing Authorisation
Sally Shorthose & Sarah Faircliffe;
CHAPTER 5 Conditional Marketing Authorisations;
Sally Shorthose;
CHAPTER 6 Supplementary Protection Certificates;
Tasmina Goraya;
CHAPTER 7 Paediatrics;
Sally Shorthose & Sarah Faircliffe;
CHAPTER 8 Advertising Medicinal Products for Human Use;
Anne-Charlotte Le Bihan, Jean-Baptiste Thiénot, Sally Shorthose, Sarah Faircliffe, Marc Martens, Nicolas Carbonnelle, Ulf Grundmann, Hanneke Later-Nijland, Mauro Turrini, Gabriel Lidman & Raquel Ballesteros;
CHAPTER 9 Pharmacovigilance;
Sally Shorthose
CHAPTER 10 Variations to Marketing Authorisations;
Tasmina Goraya;
CHAPTER 11 Combination Products;
Sarah Faircliffe;
CHAPTER 12 Abridged Procedure;
Hanneke Later-Nijland;
CHAPTER 13 Orphan Drugs;
Sarah Faircliffe;
CHAPTER 14 Biopharmaceuticals;
Marc Martens & Nicolas Carbonnelle;
CHAPTER 15 Homeopathic, Herbal, and Traditional Herbal Medicinal Products;
Hanneke Later-Nijland;
CHAPTER 16 Advanced Therapy Medicinal Products;
Marc Martens & Nicolas Carbonnelle;
CHAPTER 17 Vaccines;
Raquel Ballesteros;
CHAPTER 18 Medical Devices;
Ulf Grundmann, Alexander Csaki, Clarissa Junge-Gierse & David Janiszewski;
CHAPTER 19 Parallel Trade;
Hanneke Later-Nijland;
CHAPTER 20 Competition Law in the Pharmaceutical Sector
José Rivas & Silvia Pronk;
Appendix Guidelines and Publications;
Table of Cases;
Directives;
Other Legislation;
Regulations;
Index.